Further studies are required to elucidate the functional consequences of the interaction between RPS4X and MDM2 in cancer cells and may contribute to reinforcing the evidence that it could be a biomarker for these cancers, which may help in more effective treatment for patients. Here, RPS4X is linked to cancer.